Home  »  Companies   »  Baxter International Inc. (BAX): Analysts Provide ...

Baxter International Inc. (BAX): Analysts Provide Important Insight

Baxter International Inc. (NYSE:BAX) at last check was buoying at $39.03 on Friday, September 15, with a fall of -0.29% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $39.15 and 5Y monthly beta was reading 0.61 with its price kept floating in the range of $38.80 and $39.40 on the day. Considering stock’s 52-week price range provides that BAX hit a high price of $60.33 and saw its price falling to a low level of $37.35 during that period. Over a period of past 1-month, stock came subtracting -7.24% in its value.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


With its current market valuation of $19.92 billion, Baxter International Inc. is set to declare its quarterly results on Oct 25, 2023 – Oct 30, 2023. BAX Stock’s Forward Dividend of 1.16 and its yield of 2.97% are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter. Analysts are in estimates of $0.67 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to $2.57 for 2023 with estimates of that growing to $3.07 in next year. These estimates are suggesting current year growth of -26.60% for EPS and 19.50% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $3.7 billion. They suggested that in the process company could generate revenue of as low as $3.66 billion which could climb up to $3.77 billion to hit a high. The average estimate is representing a decrease of -2.10% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $14.76 billion in 2023, which will be -2.30% less from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with 1 upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review BAX stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 100% Sell for it.

Digging deeper we become aware of the PEG ratio of the BAX stock which is currently positioned at 0. It further provides that stock’s current price level is -3.65% away from its 20-day simple moving average and is -10.28% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 33.98 while volatility remained at 1.86% over the past week which changes to 2.23% when measuring it over the past month. Beta is valued at 0.61, while measure of average true range or ATR is currently at 0.92.

In comparing Baxter International Inc. (BAX)’s stock with other industry players reveals that stock’s latest price change of -0.29% and that of -33.96% over the past 12 months is in competing position with that of Medtronic plc (MDT) which saw its stock price fall by -0.28% in the recent trading and went through a decrease of -9.81% in past 12-month trading. Industry’s another major player Stryker Corporation (SYK) has fall -0.46% down in latest trading session, but over the past year has faced arise of 29.82%, while Becton Dickinson and Company (BDX) was also down -0.54% however its price remained floating in the green at 1.64% over the same period. Baxter International Inc. has a P/E ratio of 0 against that of Medtronic plc’s 30.08 while Stryker Corporation is showing 41.49 for the same. On the other hand, the S&P 500 Index is down -0.94% in the early deals today while the Dow Jones Industrial was dealinglower at -0.58%.

Having a second look at Baxter International Inc. (NYSE:BAX) provides that stock’s average daily trading volume for 3 months was 4.53 million, while it jumped to 3.86 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 506.00 million.

The percentage of outstanding shares held by the insiders is 0.27% while it is 89.50% for the institutional holders. The figures also indicate that as of Aug 30, 2023, number of stock’s short shares was 7.17 million which implies a short ratio of 1.9. This shows down a 1.42% of Short Interest in company’s outstanding shares on the day. In August the standing of shares short improved as it was 7.8 million in the previous month. Subtraction of -23.42% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.